Characterization and structure-activity relationship study of iminodipyridinopyrimidines as novel hepatitis C virus inhibitor
- 1 November 2017
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 140, 65-73
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (2014K1A4A7A01074644)
- Korean Government (MSIP)
- KISTI
This publication has 19 references indexed in Scilit:
- Current race in the development of DAAs (direct-acting antivirals) against HCVBiochemical Pharmacology, 2014
- A Small-Molecule Inhibitor of Hepatitis C Virus InfectivityAntimicrobial Agents and Chemotherapy, 2014
- The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entryHepatology, 2010
- Analysis of Ribavirin Mutagenicity in Human Hepatitis C Virus InfectionJournal of Virology, 2007
- Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluationHealth Technology Assessment, 2007
- Treating viral hepatitis C: efficacy, side effects, and complicationsGut, 2006
- Antiviral therapy for chronic hepatitis C: past, present, and futureJournal of Gastroenterology, 2006
- Complete Replication of Hepatitis C Virus in Cell CultureScience, 2005
- Production of infectious hepatitis C virus in tissue culture from a cloned viral genomeNature Medicine, 2005
- Robust hepatitis C virus infectionin vitroProceedings of the National Academy of Sciences, 2005